Immunogenicity of soluble and particulate antigens from Leishmania donovani: effect of glucan as an adjuvant.
The protective efficacy of glucan as an adjuvant with killed promastigotes of Leishmania donovani was compared with that of soluble or particulate fractions of the parasite. When these vaccine preparations were injected either intravenously or subcutaneously in CF-1 mice, glucan potentiated resistance against L. donovani infections as reflected by significant reductions in hepatic amastigote counts relative to infected control mice. The leishmanial antigens alone afforded no protection. Serum direct agglutination titers to leishmanial antigens were highest in all groups given the vaccine intravenously, whereas the delayed-type hypersensitivity response to the antigen was positive only in groups immunized subcutaneously with glucan as an adjuvant. Some index of protection and immune response against visceral infection with the parasite was seen in groups vaccinated with glucan and soluble antigens. However, the protection afforded by glucan and particulate antigens of L. donovani more closely paralleled the resistance of mice treated with glucan and unfractionated killed promastigotes. Further antigenic analysis of particulate fractions of L. donovani may optimize effective immunization when used with appropriate adjuvants, e.g., glucan.
D000276:Adjuvants, Immunologic; D000373:Agglutinins / Q000032:analysis; D000818:Animals; D005260:Female; D005936:Glucans / Q000276:immunology*; D006968:Hypersensitivity, Delayed; D007114:Immunization; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007891:Leishmania / Q000254:growth & development / Q000276:immunology*; D007898:Leishmaniasis, Visceral / Q000276:immunology* / Q000469:parasitology; D008099:Liver / Q000469:parasitology; D051379:Mice; D012995:Solubility
D000276:Adjuvants, Immunologic; D000373:Agglutinins; D005936:Glucans